Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan in chronic hepatitis B and D
IRCT2017071128308N3Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irbesartan in hepatitis B (HBV) and hepatitis D (HDV), sponsored by Tehran University of Medical Sciences. Started Dec 2017; status: completed.
02
Drugs
irbesartan
03
Conditions
hepatitis B (HBV)hepatitis D (HDV)
Beyond the preview
Go deeper on IRCT2017071128308N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017071128308N3.